HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved..
BACKGROUND & AIMS: Ulcerative colitis (UC) is characterized by severe inflammation and destruction of the intestinal epithelium, and is associated with specific risk single nucleotide polymorphisms in HLA class II. Given the recently discovered interactions between subsets of HLA-DP molecules and the activating natural killer (NK) cell receptor NKp44, genetic associations of UC and HLA-DP haplotypes and their functional implications were investigated.
METHODS: HLA-DP haplotype and UC risk association analyses were performed (UC: n = 13,927; control: n = 26,764). Expression levels of HLA-DP on intestinal epithelial cells (IECs) in individuals with and without UC were quantified. Human intestinal 3-dimensional (3D) organoid cocultures with human NK cells were used to determine functional consequences of interactions between HLA-DP and NKp44.
RESULTS: These studies identified HLA-DPA1∗01:03-DPB1∗04:01 (HLA-DP401) as a risk haplotype and HLA-DPA1∗01:03-DPB1∗03:01 (HLA-DP301) as a protective haplotype for UC in European populations. HLA-DP expression was significantly higher on IECs of individuals with UC compared with controls. IECs in human intestinal 3D organoids derived from HLA-DP401pos individuals showed significantly stronger binding of NKp44 compared with HLA-DP301pos IECs. HLA-DP401pos IECs in organoids triggered increased degranulation and tumor necrosis factor production by NKp44+ NK cells in cocultures, resulting in enhanced epithelial cell death compared with HLA-DP301pos organoids. Blocking of HLA-DP401-NKp44 interactions (anti-NKp44) abrogated NK cell activity in cocultures.
CONCLUSIONS: We identified an UC risk HLA-DP haplotype that engages NKp44 and activates NKp44+ NK cells, mediating damage to intestinal epithelial cells in an HLA-DP haplotype-dependent manner. The molecular interaction between NKp44 and HLA-DP401 in UC can be targeted by therapeutic interventions to reduce NKp44+ NK cell-mediated destruction of the intestinal epithelium in UC.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:165 |
|---|---|
| Enthalten in: |
Gastroenterology - 165(2023), 4 vom: 15. Okt., Seite 946-962.e13 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Baumdick, Martin E [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
HLA-DP |
|---|
| Anmerkungen: |
Date Completed 25.09.2023 Date Revised 13.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1053/j.gastro.2023.06.034 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM359556728 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM359556728 | ||
| 003 | DE-627 | ||
| 005 | 20240313233525.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1053/j.gastro.2023.06.034 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1326.xml |
| 035 | |a (DE-627)NLM359556728 | ||
| 035 | |a (NLM)37454979 | ||
| 035 | |a (PII)S0016-5085(23)04772-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Baumdick, Martin E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.09.2023 | ||
| 500 | |a Date Revised 13.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a BACKGROUND & AIMS: Ulcerative colitis (UC) is characterized by severe inflammation and destruction of the intestinal epithelium, and is associated with specific risk single nucleotide polymorphisms in HLA class II. Given the recently discovered interactions between subsets of HLA-DP molecules and the activating natural killer (NK) cell receptor NKp44, genetic associations of UC and HLA-DP haplotypes and their functional implications were investigated | ||
| 520 | |a METHODS: HLA-DP haplotype and UC risk association analyses were performed (UC: n = 13,927; control: n = 26,764). Expression levels of HLA-DP on intestinal epithelial cells (IECs) in individuals with and without UC were quantified. Human intestinal 3-dimensional (3D) organoid cocultures with human NK cells were used to determine functional consequences of interactions between HLA-DP and NKp44 | ||
| 520 | |a RESULTS: These studies identified HLA-DPA1∗01:03-DPB1∗04:01 (HLA-DP401) as a risk haplotype and HLA-DPA1∗01:03-DPB1∗03:01 (HLA-DP301) as a protective haplotype for UC in European populations. HLA-DP expression was significantly higher on IECs of individuals with UC compared with controls. IECs in human intestinal 3D organoids derived from HLA-DP401pos individuals showed significantly stronger binding of NKp44 compared with HLA-DP301pos IECs. HLA-DP401pos IECs in organoids triggered increased degranulation and tumor necrosis factor production by NKp44+ NK cells in cocultures, resulting in enhanced epithelial cell death compared with HLA-DP301pos organoids. Blocking of HLA-DP401-NKp44 interactions (anti-NKp44) abrogated NK cell activity in cocultures | ||
| 520 | |a CONCLUSIONS: We identified an UC risk HLA-DP haplotype that engages NKp44 and activates NKp44+ NK cells, mediating damage to intestinal epithelial cells in an HLA-DP haplotype-dependent manner. The molecular interaction between NKp44 and HLA-DP401 in UC can be targeted by therapeutic interventions to reduce NKp44+ NK cell-mediated destruction of the intestinal epithelium in UC | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Intramural | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a HLA-DP | |
| 650 | 4 | |a Intestinal Organoids | |
| 650 | 4 | |a NK Cells | |
| 650 | 4 | |a NKp44 | |
| 650 | 4 | |a Ulcerative Colitis | |
| 650 | 7 | |a HLA-DP Antigens |2 NLM | |
| 700 | 1 | |a Niehrs, Annika |e verfasserin |4 aut | |
| 700 | 1 | |a Degenhardt, Frauke |e verfasserin |4 aut | |
| 700 | 1 | |a Schwerk, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Hinrichs, Ole |e verfasserin |4 aut | |
| 700 | 1 | |a Jordan-Paiz, Ana |e verfasserin |4 aut | |
| 700 | 1 | |a Padoan, Benedetta |e verfasserin |4 aut | |
| 700 | 1 | |a Wegner, Lucy H M |e verfasserin |4 aut | |
| 700 | 1 | |a Schloer, Sebastian |e verfasserin |4 aut | |
| 700 | 1 | |a Zecher, Britta F |e verfasserin |4 aut | |
| 700 | 1 | |a Malsy, Jakob |e verfasserin |4 aut | |
| 700 | 1 | |a Joshi, Vinita R |e verfasserin |4 aut | |
| 700 | 1 | |a Illig, Christin |e verfasserin |4 aut | |
| 700 | 1 | |a Schröder-Schwarz, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Möller, Kimberly J |e verfasserin |4 aut | |
| 700 | 0 | |a Hamburg Intestinal Tissue Study Group |e verfasserin |4 aut | |
| 700 | 1 | |a Martin, Maureen P |e verfasserin |4 aut | |
| 700 | 1 | |a Yuki, Yuko |e verfasserin |4 aut | |
| 700 | 1 | |a Ozawa, Mikki |e verfasserin |4 aut | |
| 700 | 1 | |a Sauter, Jürgen |e verfasserin |4 aut | |
| 700 | 1 | |a Schmidt, Alexander H |e verfasserin |4 aut | |
| 700 | 1 | |a Perez, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Giannou, Anastasios D |e verfasserin |4 aut | |
| 700 | 1 | |a Carrington, Mary |e verfasserin |4 aut | |
| 700 | 1 | |a Davis, Randall S |e verfasserin |4 aut | |
| 700 | 1 | |a Schumacher, Udo |e verfasserin |4 aut | |
| 700 | 1 | |a Sauter, Guido |e verfasserin |4 aut | |
| 700 | 1 | |a Huber, Samuel |e verfasserin |4 aut | |
| 700 | 1 | |a Puelles, Victor G |e verfasserin |4 aut | |
| 700 | 1 | |a Melling, Nathaniel |e verfasserin |4 aut | |
| 700 | 1 | |a Franke, Andre |e verfasserin |4 aut | |
| 700 | 0 | |a International Inflammatory Bowel Disease Genetics Consortium |e verfasserin |4 aut | |
| 700 | 1 | |a Altfeld, Marcus |e verfasserin |4 aut | |
| 700 | 1 | |a Bunders, Madeleine J |e verfasserin |4 aut | |
| 700 | 1 | |a Akar, Alaa |e investigator |4 oth | |
| 700 | 1 | |a Flemming, Cornelius |e investigator |4 oth | |
| 700 | 1 | |a Felix |e investigator |4 oth | |
| 700 | 1 | |a Flomm |e investigator |4 oth | |
| 700 | 1 | |a Flosbach, Markus |e investigator |4 oth | |
| 700 | 1 | |a Jäger, Julia |e investigator |4 oth | |
| 700 | 1 | |a Jeromin, Niklas |e investigator |4 oth | |
| 700 | 1 | |a Jung, Johannes |e investigator |4 oth | |
| 700 | 1 | |a Ohms, Mareike |e investigator |4 oth | |
| 700 | 1 | |a Reinshagen, Konrad |e investigator |4 oth | |
| 700 | 1 | |a Rische, Johann |e investigator |4 oth | |
| 700 | 1 | |a Sagebiel, Adrian |e investigator |4 oth | |
| 700 | 1 | |a Sandfort, Deborah |e investigator |4 oth | |
| 700 | 1 | |a Steinert, Fenja |e investigator |4 oth | |
| 700 | 1 | |a Tomuschat, Christian |e investigator |4 oth | |
| 700 | 1 | |a Wesche, Jasmin |e investigator |4 oth | |
| 700 | 1 | |a Shifteh Abedian |e investigator |4 oth | |
| 700 | 1 | |a Abraham, Clara |e investigator |4 oth | |
| 700 | 1 | |a Achkar, Jean-Paul |e investigator |4 oth | |
| 700 | 1 | |a Ahmad, Tariq |e investigator |4 oth | |
| 700 | 1 | |a Alberts, Rudi |e investigator |4 oth | |
| 700 | 1 | |a Alizadeh, Behrooz |e investigator |4 oth | |
| 700 | 1 | |a Amininejad, Leila |e investigator |4 oth | |
| 700 | 1 | |a Ananthakrishnan, Ashwin N |e investigator |4 oth | |
| 700 | 1 | |a Andersen, Vibeke |e investigator |4 oth | |
| 700 | 1 | |a Anderson, Carl A |e investigator |4 oth | |
| 700 | 1 | |a Andrews, Jane M |e investigator |4 oth | |
| 700 | 1 | |a Annese, Vito |e investigator |4 oth | |
| 700 | 1 | |a Aumais, Guy |e investigator |4 oth | |
| 700 | 1 | |a Baidoo, Leonard |e investigator |4 oth | |
| 700 | 1 | |a Baldassano, Robert N |e investigator |4 oth | |
| 700 | 1 | |a Bampton, Peter A |e investigator |4 oth | |
| 700 | 1 | |a Barclay, Murray |e investigator |4 oth | |
| 700 | 1 | |a Barrett, Jeffrey C |e investigator |4 oth | |
| 700 | 1 | |a Bethge, Johannes |e investigator |4 oth | |
| 700 | 1 | |a Bewshea, Claire |e investigator |4 oth | |
| 700 | 1 | |a Bis, Joshua C |e investigator |4 oth | |
| 700 | 1 | |a Bitton, Alain |e investigator |4 oth | |
| 700 | 1 | |a Bk, Thelma |e investigator |4 oth | |
| 700 | 1 | |a Boucher, Gabrielle |e investigator |4 oth | |
| 700 | 1 | |a Brain, Oliver |e investigator |4 oth | |
| 700 | 1 | |a Brand, Stephan |e investigator |4 oth | |
| 700 | 1 | |a Brant, Steven R |e investigator |4 oth | |
| 700 | 1 | |a Cheon, Jae Hee |e investigator |4 oth | |
| 700 | 1 | |a Chew, Angela |e investigator |4 oth | |
| 700 | 1 | |a Cho, Judy H |e investigator |4 oth | |
| 700 | 1 | |a Cleynen, Isabelle |e investigator |4 oth | |
| 700 | 1 | |a Cohain, Ariella |e investigator |4 oth | |
| 700 | 1 | |a Cooney, Rachel |e investigator |4 oth | |
| 700 | 1 | |a Croft, Anthony |e investigator |4 oth | |
| 700 | 1 | |a Daly, Mark J |e investigator |4 oth | |
| 700 | 1 | |a D'Amato, Mauro |e investigator |4 oth | |
| 700 | 1 | |a Danese, Silvio |e investigator |4 oth | |
| 700 | 1 | |a Daryani, Naser Ebrahim |e investigator |4 oth | |
| 700 | 1 | |a Datta, Lisa Wu |e investigator |4 oth | |
| 700 | 1 | |a Degenhardt, Frauke |e investigator |4 oth | |
| 700 | 1 | |a Denapiene, Goda |e investigator |4 oth | |
| 700 | 1 | |a Denson, Lee A |e investigator |4 oth | |
| 700 | 1 | |a Devaney, Kathy L |e investigator |4 oth | |
| 700 | 1 | |a Dewit, Olivier |e investigator |4 oth | |
| 700 | 1 | |a D'Inca, Renata |e investigator |4 oth | |
| 700 | 1 | |a Drummond, Hazel E |e investigator |4 oth | |
| 700 | 1 | |a Dubinsky, Marla |e investigator |4 oth | |
| 700 | 1 | |a Duerr, Richard H |e investigator |4 oth | |
| 700 | 1 | |a Edwards, Cathryn |e investigator |4 oth | |
| 700 | 1 | |a Ellinghaus, David |e investigator |4 oth | |
| 700 | 1 | |a Ellul, Pierre |e investigator |4 oth | |
| 700 | 1 | |a Esaki, Motohiro |e investigator |4 oth | |
| 700 | 1 | |a Essers, Jonah |e investigator |4 oth | |
| 700 | 1 | |a Ferguson, Lynnette R |e investigator |4 oth | |
| 700 | 1 | |a Festen, Eleonora A |e investigator |4 oth | |
| 700 | 1 | |a Fleshner, Philip |e investigator |4 oth | |
| 700 | 1 | |a Florin, Tim |e investigator |4 oth | |
| 700 | 1 | |a Franchimont, Denis |e investigator |4 oth | |
| 700 | 1 | |a Franke, Andre |e investigator |4 oth | |
| 700 | 1 | |a Fuyuno, Yuta |e investigator |4 oth | |
| 700 | 1 | |a Gearry, Richard |e investigator |4 oth | |
| 700 | 1 | |a Georges, Michel |e investigator |4 oth | |
| 700 | 1 | |a Gieger, Christian |e investigator |4 oth | |
| 700 | 1 | |a Glas, Jürgen |e investigator |4 oth | |
| 700 | 1 | |a Goyette, Philippe |e investigator |4 oth | |
| 700 | 1 | |a Green, Todd |e investigator |4 oth | |
| 700 | 1 | |a Griffiths, Anne M |e investigator |4 oth | |
| 700 | 1 | |a Guthery, Stephen L |e investigator |4 oth | |
| 700 | 1 | |a Hakonarson, Hakon |e investigator |4 oth | |
| 700 | 1 | |a Halfvarson, Jonas |e investigator |4 oth | |
| 700 | 1 | |a Hanigan, Katherine |e investigator |4 oth | |
| 700 | 1 | |a Haritunians, Talin |e investigator |4 oth | |
| 700 | 1 | |a Hart, Ailsa |e investigator |4 oth | |
| 700 | 1 | |a Hawkey, Chris |e investigator |4 oth | |
| 700 | 1 | |a Hayward, Nicholas K |e investigator |4 oth | |
| 700 | 1 | |a Hedl, Matija |e investigator |4 oth | |
| 700 | 1 | |a Henderson, Paul |e investigator |4 oth | |
| 700 | 1 | |a Hold, Georgina L |e investigator |4 oth | |
| 700 | 1 | |a Hong, Myhunghee |e investigator |4 oth | |
| 700 | 1 | |a Hu, Xinli |e investigator |4 oth | |
| 700 | 1 | |a Huang, Hailiang |e investigator |4 oth | |
| 700 | 1 | |a Hugot, Jean-Pierre |e investigator |4 oth | |
| 700 | 1 | |a Hui, Ken Y |e investigator |4 oth | |
| 700 | 1 | |a Imielinski, Marcin |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Gastroenterology |d 1945 |g 165(2023), 4 vom: 15. Okt., Seite 946-962.e13 |w (DE-627)NLM00001706X |x 1528-0012 |7 nnns |
| 773 | 1 | 8 | |g volume:165 |g year:2023 |g number:4 |g day:15 |g month:10 |g pages:946-962.e13 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1053/j.gastro.2023.06.034 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 165 |j 2023 |e 4 |b 15 |c 10 |h 946-962.e13 | ||